Varma Mutual Pension Insurance Co Buys 10,130 Shares of Axon Enterprise, Inc $AXON

Varma Mutual Pension Insurance Co grew its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 69.9% during the fourth quarter, Holdings Channel reports. The firm owned 24,630 shares of the biotechnology company’s stock after purchasing an additional 10,130 shares during the period. Varma Mutual Pension Insurance Co’s holdings in Axon Enterprise were worth $13,988,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Sun Financial Inc bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $1,025,000. Oak Harbor Wealth Partners LLC lifted its holdings in Axon Enterprise by 5.0% during the fourth quarter. Oak Harbor Wealth Partners LLC now owns 856 shares of the biotechnology company’s stock worth $486,000 after acquiring an additional 41 shares during the period. Pittenger & Anderson Inc. lifted its holdings in Axon Enterprise by 23,900.0% during the fourth quarter. Pittenger & Anderson Inc. now owns 1,440 shares of the biotechnology company’s stock worth $818,000 after acquiring an additional 1,434 shares during the period. Benjamin Edwards Inc. lifted its holdings in Axon Enterprise by 2.1% during the fourth quarter. Benjamin Edwards Inc. now owns 2,227 shares of the biotechnology company’s stock worth $1,265,000 after acquiring an additional 46 shares during the period. Finally, Strs Ohio lifted its holdings in Axon Enterprise by 12.9% during the fourth quarter. Strs Ohio now owns 39,287 shares of the biotechnology company’s stock worth $22,312,000 after acquiring an additional 4,503 shares during the period. Institutional investors own 79.08% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on AXON. Barclays dropped their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. UBS Group dropped their price target on Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a report on Wednesday, February 25th. Morgan Stanley reiterated an “overweight” rating on shares of Axon Enterprise in a report on Wednesday, April 8th. JPMorgan Chase & Co. dropped their price target on Axon Enterprise from $925.00 to $750.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Finally, Royal Bank Of Canada dropped their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus target price of $749.63.

Insiders Place Their Bets

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the sale, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at $7,019,028. This trade represents a 10.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the sale, the director directly owned 1,946 shares of the company’s stock, valued at $985,804.68. This represents a 9.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 13,855 shares of company stock valued at $7,109,828. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $393.75 on Tuesday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The business has a fifty day simple moving average of $454.05 and a two-hundred day simple moving average of $532.97. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $885.91. The company has a market capitalization of $31.73 billion, a P/E ratio of 259.05, a P/E/G ratio of 8.59 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business had revenue of $796.72 million during the quarter, compared to the consensus estimate of $755.29 million. During the same period last year, the business posted $2.08 earnings per share. The business’s revenue for the quarter was up 38.5% on a year-over-year basis. On average, analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.